Prognostic value of translocation t(11;18) in tumoral response of low-grade gastric lymphoma of mucosa-associated lymphoid tissue type to oral chemotherapy
about
A critical role for the NFkB pathway in multiple myeloma.Chlorambucil versus observation after anti-Helicobacter therapy in gastric MALT lymphomas: results of the international randomised LY03 trialTreatment of gastric mucosa-associated lymphoid tissue lymphoma: Helicobacter pylori eradication and beyond.Mucosa-associated lymphoid tissue (MALT) lymphoma: a practical guide for pathologists.Marginal zone lymphoma: old, new, targeted, and epigenetic therapies.Therapy of gastric mucosa-associated lymphoid tissue lymphoma.Therapy of gastric mucosa associated lymphoid tissue lymphoma.Primary extranodal lymphomas of stomach: clinical presentation, diagnostic pitfalls and management.Malt1 and cIAP2-Malt1 as effectors of NF-kappaB activation: kissing cousins or distant relatives?Treatment of gastric marginal zone lymphoma of MALT type.Treatment of gastric MALT lymphoma with a focus on Helicobacter pylori eradication.Clinical aspects of malt lymphomas.Treatment of t(11;18)-positive gastric mucosa-associated lymphoid tissue lymphoma with rituximab and chlorambucil: clinical, histological, and molecular follow-up.Rituximab and chlorambucil versus rituximab alone in gastric mucosa-associated lymphoid tissue lymphoma according to t(11;18) status: a monocentric non-randomized observational study.Gastric mucosa-associated lymphoid tissue lymphoma resistant to Helicobacter pylori eradication: what's the best option?Effective management strategies for patients with marginal zone lymphoma.New cancer cases in France in 2015 attributable to infectious agents: a systematic review and meta-analysis.Molecular history of Richter syndrome: origin from a cell already present at the time of chronic lymphocytic leukemia diagnosis.Characteristics of Helicobacter pylori-positive and Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma and their influence on clinical outcome
P2860
Q34165181-2E76C783-74E1-4044-B398-35EDB97302BEQ34600972-58E04F2C-A0B9-4EDA-9584-234469BC937AQ36407449-24C8AB2F-A0FB-48FC-A380-B3DFF0863CF5Q36584820-48FC5750-5690-4175-963F-C30D3B7B02E2Q36768594-51803599-9D14-4DE6-AAC4-CD08B6771933Q36847291-AAF6AA37-5EC8-4864-8DCA-CC22AF2E5D79Q36894785-02DB7978-8ED4-462C-B0DA-F34D1A5CC692Q37224102-BCA61306-3E6D-4149-8DA1-D003D99A760AQ37397689-7D30FA56-BA5F-4B5D-9D12-A9214B6CEDBDQ37768456-3788CAE2-5B9F-46F3-ABAA-57F8599F3CD7Q38101527-2D97EE99-DA3D-44A0-A438-9BB93E84A471Q38252813-892659B9-652D-4D7E-B4DB-69D383323018Q43206352-83D6AEB2-FF6A-421F-AC86-F6F9AAA656E1Q43862285-AD756F48-49C7-401A-BFA7-D31E987601EFQ45827489-E7901053-D707-4C9A-B0A4-C25E227BB8F4Q47278073-54AF08C7-AD51-4ED1-8A60-D9D95E5EA9A3Q47353782-F0BAE337-858E-426F-9605-7AACFA64059FQ52614373-EB861E91-199F-4307-A399-A18FABE1B9E0Q57224018-9787D3A0-05D1-4861-B259-34D5F58EE5F6
P2860
Prognostic value of translocation t(11;18) in tumoral response of low-grade gastric lymphoma of mucosa-associated lymphoid tissue type to oral chemotherapy
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Prognostic value of translocat ...... ssue type to oral chemotherapy
@ast
Prognostic value of translocat ...... ssue type to oral chemotherapy
@en
Prognostic value of translocat ...... ssue type to oral chemotherapy
@nl
type
label
Prognostic value of translocat ...... ssue type to oral chemotherapy
@ast
Prognostic value of translocat ...... ssue type to oral chemotherapy
@en
Prognostic value of translocat ...... ssue type to oral chemotherapy
@nl
prefLabel
Prognostic value of translocat ...... ssue type to oral chemotherapy
@ast
Prognostic value of translocat ...... ssue type to oral chemotherapy
@en
Prognostic value of translocat ...... ssue type to oral chemotherapy
@nl
P2093
P50
P356
P1476
Prognostic value of translocat ...... ssue type to oral chemotherapy
@en
P2093
Antoine Charachon
Christine Gameiro
François Hemery
Jean-Charles Delchier
Marie-Hélène Delfau-Larue
Marie-Thérèse Chaumette
Michaël Lévy
Philippe Gaulard
P304
P356
10.1200/JCO.2005.05.660
P407
P577
2005-08-01T00:00:00Z